These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4971419)

  • 1. [Chelates in the treatment of obliterating arterial diseases. (Preliminary report)].
    Brücknerová O; Tulácek J; Krojzl O
    Vnitr Lek; 1968 Sep; 14(9):841-5. PubMed ID: 4971419
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
    Buccellato C; Di Lorenzo GD
    Minerva Chir; 1967 Jun; 22(11):692-5. PubMed ID: 6050666
    [No Abstract]   [Full Text] [Related]  

  • 3. [Medical therapy of obliterating arteriopathies].
    Schwarz D
    Minerva Med; 1969 Oct; 60(87):4335-44. PubMed ID: 4242895
    [No Abstract]   [Full Text] [Related]  

  • 4. [A method of insulin therapy of chronic obliterating arteriopathies. Clinical results and etiopathogenetic considerations].
    Bonessa C; Cremonini L
    Minerva Med; 1966 Jul; 57(44):2027-40. PubMed ID: 5942708
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intra-arterial treatment of arterial obliterative disease (author's transl)].
    Mörl H
    Dtsch Med Wochenschr; 1974 Nov; 99(45):2284-6. PubMed ID: 4448136
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the action of p-chlorophenoxy alpha-isobutyrate of 3-hydroxymethyl pyridine hydrochloride on peripheral circulation. Rheographic and radioisotope studies].
    Modica G; Ferrante R
    Minerva Cardioangiol; 1973 Dec; 21(12):769-74. PubMed ID: 4592148
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intra-arterial administration of pyrrolidin-methyl-tetracycline in the treatment of various obliterative angiopathies].
    Del Corso P; Zeme D; Beverelli M
    Clin Ter; 1970 Nov; 55(3):231-8. PubMed ID: 5516887
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ozone therapy, a new method of treating chronic obliterating arteriopathies].
    Ionescu G; Pitea P; Blaj A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(3):207-13. PubMed ID: 2931752
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
    Blasi A; Licciardello M
    Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chelates in the treatment of occlusive arteriosclerosis].
    Brücknerová O; Tulácek J
    Vnitr Lek; 1972 Aug; 18(8):729-36. PubMed ID: 4626555
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intra-arterial infusions of solcoseryl in the treatment of obliterative diseases of the peripheral arteries in the polyclinic].
    Kozlitskiĭ AP
    Vestn Khir Im I I Grek; 1982 Sep; 129(9):120-3. PubMed ID: 7147583
    [No Abstract]   [Full Text] [Related]  

  • 12. [Continuous intra-arterial infusions in obliterating diseases of the lower limbs].
    Chudakov MI; Vorotyntsev SF
    Khirurgiia (Mosk); 1974 May; (5):87-90. PubMed ID: 4457694
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the therapy of peripheral arteriosclerosis obliterans].
    Pupita F; Stefanelli G
    Minerva Cardioangiol; 1968 Nov; 16(11):1083-93. PubMed ID: 5707453
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of peripheral arterial circulation disorders using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Denck H
    Arzneimittelforschung; 1973 Apr; 23(4):571-3. PubMed ID: 4740236
    [No Abstract]   [Full Text] [Related]  

  • 15. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. I. Clinical results in various evolutive phases].
    Zanelli G; Ferrero S; Patrone P
    Minerva Cardioangiol; 1971 Nov; 19(11):605-15. PubMed ID: 5128422
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin in the treatment of trophic disorders caused by chronic obliterating arteriopathies].
    Cascone A; Ferrari F
    G Gerontol; 1968 Dec; 16(12):1385-94. PubMed ID: 5732590
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
    Cascio F
    Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rheographic study of the activity of some vasoactive drugs on peripheral arterial circulation].
    Capitanucci P; Martinelli M; De Gregorio M
    Minerva Cardioangiol; 1968 Nov; 16(11):1074-82. PubMed ID: 5707452
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the therapeutic activity of hemaseril in treatment of ischemic arteriopathies and phlebopathies].
    Tattoni G; Bigazzi P; Gritta G
    Clin Ter; 1974 Mar; 69(3):225-39. PubMed ID: 4846656
    [No Abstract]   [Full Text] [Related]  

  • 20. [Test of active vasodilatation in the evaluation of peripheral regional circulation in sclerotic and diabetic arteriopathies].
    Dughera L; Macchioni P; Di Leo M; Nosenzo C
    Minerva Cardioangiol; 1972 Sep; 20(9):484-96. PubMed ID: 5071470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.